Dr. Zhou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
183 North Mountain Road, Hartford Healthcare Cancer Institute
New Britain, CT 06053Phone+1 860-827-4180Fax+1 860-223-0132
Summary
- Dr. Xun Clare Zhou is a gynecologic oncologist in New Britain, CT and is affiliated with multiple hospitals in the area, including The Hospital of Central Connecticut, Hartford Hospital and MidState Medical Center. She received her medical degree from Harvard Medical School and has been in practice 16 years. She specializes in gynecologic oncology and is experienced in cancer genetics, vulvar carcinoma, cervical carcinoma, endometrial carcinoma, and ovarian carcinoma.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gynecologic Oncology, 2005 - 2008
Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 2001 - 2005
Harvard Medical SchoolClass of 2001
Certifications & Licensure
CT State Medical License 2008 - 2025
MN State Medical License 2005 - 2009
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 14 citationsPrognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study.Giuseppe Cucinella, Gabriella Schivardi, Xun Clare Zhou, Mariam AlHilli, Sumer Wallace
International Journal of Gynecological Cancer. 2024-02-05 - 30 citationsOncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: An international multi-institutional studyKhaled Ghoniem, Alyssa Larish, Giorgia Dinoi, Xun Clare Zhou, Mariam AlHilli
Gynecologic Oncology. 2021-09-01 - 52 citationsMutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study.Kimberly K. Leslie, Virginia L. Filiaci, Adrianne R. Mallen, Kristina W. Thiel, Eric J. Devor
Gynecologic Oncology. 2021-04-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
